| Net cash provided by operating activities | 11.97M |
| Capital expenditures | -6.62M |
| Grants received for capital expenditures | |
| Proceeds from property, plant, and equipment disposals | 1.02M |
| Net cash used in investing activities | -5.6M |
| Net payments of commercial paper | |
| Net payments under credit agreement | |
| Borrowings under credit agreement | 11.5M |
| Payments under credit agreement | -13.23M |
| Issuances of notes payable | |
| Payments under notes payable obligations | |
| Payment of premium on early extinguishment of debt | 0 |
| Dividends paid | -4.51M |
| Proceeds from stock option exercises | 0 |
| Net cash provided by financing activities | -6.23M |
| Net (decrease) increase in cash and cash equivalents | 136K |
| Cash and cash equivalents, beginning of period | 2.68M |
| Cash and cash equivalents, end of period | 2.81M |